Total Number of Communication Reports: 6
Monthly communication reports in the last 6 months: 0
Entos Pharmaceuticals is developing a COVID-19 vaccine. Entos wishes to communicate and seek the federal government's support for a “made in Canada” solution to COVID-19.
John Lewis, Chief Executive Officer
Address:
Unit 4550, 10230 Jasper Avenue
Edmonton, AB T5J 4P6
Canada
Telephone number:
780-862-7445
Entos Pharmaceuticals is not a subsidiary of any other parent companies.
Entos Pharmaceuticals does not have any subsidiaries that could have a direct interest in the outcome of the undertaking